ReviewEuropean journal of pharmacology2019

SGLT2 inhibitors and metformin: Dual antihyperglycemic therapy and the risk of metabolic acidosis in type 2 diabetes.

Katherine Donnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.